Transparency Market Research observes that the global radiation oncology market is projected to grow. This observation in based on WHO’s report that states there is likely to be a 70% rise in the number of cancer patients in the next 20 years. The unstoppable rise in the number of cancer cases is expected to be the primary growth driver for the global market in the coming few years.
The research report on the global market studies the various aspects influencing the trajectory of the global market along with identifying the drivers and restraints. The research report, titled “Radiation Oncology Market – Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2013 – 2019,” provides a thorough outlook of the market to its readers through meticulously collaborated chapters.
View Exclusive Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1354
The noteworthy improvements in radiation technologies are also anticipated to contribute positively to the rising revenue of the global radiation oncology market in the near future. The rising disposable incomes in developing regions, a high prevalence of cancer across the globe, and growing the awareness of cancer are all playing a vital role in the growth of the global market. Currently, the market offers three types of radiation therapies such as the brachytherapy, the radioisotope therapy, and the external beam radiation therapy.
In terms of regions, the global market is segmented into North America, Asia Pacific, Europe, and the Rest of the World. Of these, North America is leading the global radiation oncology market due to high awareness about the disease. Furthermore, increasing research and development in designing effective technologies, higher adoption rate, and an increasing geriatric population, which is highly susceptible to these chronic conditions is likely to boost the demand for radiation therapies in the coming few years.
Asia Pacific is also anticipated to be an emerging market for radiation oncology as the regional expenditure on healthcare is gradually improving along with its patient population. However, the global market faces certain challenges such as poor reimbursement policies and unaffordable nature of treatment.
Some of the leading players operating in the global radiation oncology market are Electa AB, Accuray Inc., Siemens Healthcare, and Varian Medical Systems. The research report profiles these players and offers a comprehensive review of the competitive landscape in the global market. The report includes a Porter’s five forces analysis that explains the intensity of the competitive rivalry, the bargaining power of buyers and suppliers, and the threat of the new entrants. The report also includes recommendations from industry experts to help the existing players, readers, and the new entrants formulate well-informed business decisions for the long run.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453